T he presence of glucose degradation products (GDP) is thought to compromise the biocompatibility of conventional peritoneal dialysis fluids (PDF). Recent in vitro studies have convincingly demonstrated toxicity of GDP toward human peritoneal mesothelial cells (HPMC) (1, 2) . GDP exert their cytotoxic effects largely by promoting glycation of vital cell proteins. The GDP identified chemically to date include methylglyoxal and glyoxal (3) . These reactive α-oxoaldehydes can be metabolized by the glyoxalase (GLO) system present in all cells [reviewed in (4) ]. The system catalyzes conversion of oxoaldehydes into nontoxic derivatives. The key element of this pathway is glyoxalase I (GLO-I), activity of which requires the presence of reduced glutathione (GSH). Interestingly, it has been shown that exposure to PDF led to glutathione depletion in HPMC in vitro (5) . Hypothetically, this effect may limit GLO-I activity and favor GDP-mediated formation of advanced glycation end-products (AGE). In this respect, peritoneal accumulation of AGE has been detected in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) (6) . On the other hand, Inagi et al. have recently demonstrated that incubation of PDF with a combination of GLO-I and glutathione, and to lesser extent with glutathione alone, can effectively and dose-dependently eliminate a substantial portion of the methylglyoxal and glyoxal present in PDF (7) . In the present study, we examined how exposure to PDF affects the GLO system in HPMC. Furthermore, we assessed the viability and function of HPMC exposed to PDF supplemented with GLO-I and glutathione .
METHODS

MATERIALS
Unless otherwise stated, all chemicals and tissue culture plastics were purchased from Sigma (Deisenhofen, Germany) and Nunc (Roskilde, Denmark) respectively.
Human peritoneal mesothelial cells were isolated from consenting nonuremic patients undergoing elective abdominal surgery. Cells were characterized and maintained in culture as described in detail elsewhere (8) . The standard culture medium used was M199 supplemented with L-glutamine (2 mmol/L), penicillin (100 U/mL), streptomycin (100 µg/mL), hydrocortisone (0.4 µg/mL), and 10% v/v fetal calf serum (FCS; Invitrogen, Eggenstein, Germany). All experiments were performed using cells from the first three passages only and not later to avoid using senescent cells, which appear in later subcultures (8) .
TEST SOLUTIONS
Dialysis solutions were prepared according to the following formula (g/L): NaCl 5.786, CaCl 2 × 2H 2 O 0.257, MgCl 2 × 6H 2 O 0.102, sodium D/L-lactate 3.925, and anhydrous D-glucose 15.0 or 42.5. The solutions were sterilized either by heat (H-PDF) or by filtration (F-PDF), which gave solutions with or without GDP respectively (9) . All PDF were neutralized to pH 7.3 with 0.1 mol/L NaHCO 3 . Immediately prior to the experiments, H-PDF was incubated in the presence or absence of a mixture of GLO-I (10 U/mL) and GSH (2 mmol/L) for 1 hour at 37°C. Doses and time of incubation were chosen based on the study by Inagi et al., which demonstrated that, under these conditions, the PDF concentrations of glyoxal and methylglyoxal could be reduced by more than 90%, and that of 3-deoxyglucosone by approximately 60% (7) . In additional experiments, PDF were pretreated with increasing doses (from 0.4 to 10 mmol/L) of GSH alone.
EXPOSURE OF HPMC TO PDF
Cells were grown to confluence, rendered quiescent by serum deprivation for 48 hours, and then exposed for the next 24 hours to pH-neutral PDF mixed with an equal volume of standard control medium. After the pretreatment phase, the test solutions still contained GLO-I and/or GSH; therefore, mixing with culture medium reduced their concentrations by half. In addition, some cells were treated with interleukin (IL)-1β (100 pg/mL) to stimulate the production of IL-6. In separate experiments, HPMC were pretreated with 1 mmol/L L-2-oxothiazolidine-carboxylic acid (OTZ) for 3 hours prior to the exposure to PDF. OTZ is a 5-oxoproline analog that is metabolized to cysteine, the rate-limiting amino acid for GSH synthesis. In these experiments, PDF was not pretreated with GLO-I and/or GSH; it was applied in a mixture with an equal volume of culture medium, as described above.
After the exposure, cell viability was measured using the MTT test (9) . The supernates were collected and measured for IL-6 using DuoSet Immunoassay (R&D Systems, Wiesbaden, Germany) according to the manufacturer's instructions. Cells were then carefully washed with phosphate-buffered saline, harvested with 0.04% EDTA, lysed with distilled H 2 O, and homogenized by sonication (9 cycles of 10 seconds each; Bandelin Sonicator, Berlin, Germany). The concentration of protein in cell homogenates was determined with the method of Bradford (10), using Bio-Rad Protein Assay Dye Reagent (Bio-Rad Laboratories, Munich, Germany). The homogenates were stored at -80°C until assayed.
BIOCHEMICAL ANALYSIS
Glyoxalase I activity was determined according to McLellan and Thornalley (11) . The method is based on the measurement of absorbance at 240 nm, an increase in which results from S-D-lactoylglutathione formation. The assay mixture contained 3.34 mmol/L methylglyoxal and 3.34 mmol/L GSH in phosphate buffer, pH 6.8. The mixture was allowed to equilibrate for 1 hour at 25°C to ensure the formation of hemithioacetal (the substrate for GLO-I). The reaction was initiated by adding 20 -60 µg of cell homogenate. The resulting increase in absorbance was followed for 2 minutes at 25°C [ Figure  1 (a)]. One unit of GLO-I activity was defined as the formation of 1 µmol S-D-lactoylglutathione. Since sample storage conditions have been shown to strongly affect the activity of GLO-I (12), we first assessed the stability of GLO-I activity in HMPC extracts stored at -80°C for various periods of time. Repeated measurements revealed that GLO-I activity gradually decreased to approximately 40% of the initial value after 3 months [ Figure 1(b) ]. Therefore, all subsequent measurements were performed within 3 days after sample preparation, with all experimental groups always being assayed in parallel.
Total intracellular glutathione was measured with the glutathione reductase-based procedure described by Tietze (13) . The assay detects both GSH and glutathione disulfide (GSSG), which is formed upon oxidation. Griffith's modification with the use 2-vinylpyridine for derivatizing GSH was used to selectively determine GSSG (14) . Accordingly, the difference in glutathione concentrations recorded in the absence and in the presence of 2-vinylpyridine reflected the concentration of GSH. Total RNA from HPMC cultures was extracted with the RNA Bee (Tel-Test, Friendswood, Texas, USA) and purified according to the manufacturer's protocol. One microgram of RNA was reverse transcribed into cDNA with random hexamer primers, as described elsewhere (15) . Expression of GLO-I mRNA was assessed by PCR as summarized in Table 1 . The specific PCR primers were synthesized by TIB MolBiol Syntheselabor, Berlin, Germany. The PCR products were separated by electrophoresis in ethidium bromide-stained 3% agarose gels and visualized under UV illumination.
STATISTICAL ANALYSIS
Statistical analyses were performed using GraphPad Prism 4.00 software (GraphPad Software, San Diego, California, USA). Comparisons were made with re- loss of its reduced form (GSH). Analysis performed in seven selected cell lines showed that GSH fell from (pmol/µg cell protein) 17.9 ± 8.2 in control cells to 5.6 ± 2.8 in cells treated with 4.25%-glucose H-PDF (n = 7, p < 0.01). No significant difference was found in absolute GSSG levels (2.6 ± 1.0 vs 1.9 ± 1.6 pmol/µg cell protein). However, the GSH/GSSG ratio, which averaged 6.9 in control cells, decreased to 3.0 in cells exposed to 4.25%-glucose H-PDF. Comparison of total cellular glutathione and GLO-I in the same samples revealed a significant correlation between these parameters [ Figure 3(c) ]. The alterations caused by 4.25%-glucose H-PDF were also associated with a significant decrease in cell viability, as assessed by the MTT test [ Figure 3(d) ]. In contrast, in cells treated with a solution of the same glucose concentration but sterilized by filtration, GLO-I activity, glutathione content, and cell viability did not differ statistically from values recorded in control cells. Solutions with lower concentration of glucose (1.5%), sterilized either by heat or filtration, did not significantly affect any of the parameters studied.
Pretreatment of 4.25%-glucose H-PDF with a combination of GLO-I and GSH markedly reduced its subsequent inhibitory effects toward HPMC. Cell viability increased to the level observed in response to 4.25%-glucose F-PDF and in control cells [ Figure 4(a) ]. The concentration of IL-6 generated by HPMC almost doubled; however, it did not quite reach the amount produced by either control cells or cells exposed to F-PDF [ Figure 4(b) ]. A very similar pattern was observed when 4.25%-glucose H-PDF was pretreated with GSH alone: GSH dose-dependently reduced the cytotoxic effects exerted by 4.25%-glucose H-PDF. The release of IL-1β-induced IL-6 increased to the level observed in cells treated with a combination of GLO-I and GSH, although it was below the level seen in control cells and cells exposed to F-PDF. In contrast, the activity of mitochondrial dehydrogenases (measured in the MTT test) in cells exposed to GSH was equal or even greater compared with control cells.
In order to determine how the availability of GSH affects the activity of GLO-I, a representative HPMC line was pretreated with OTZ (a GSH precursor) and then exposed to 4.25%-glucose H-PDF. As observed earlier, in untreated cells both the GSH/GSSG ratio and GLO-I activity decreased. In contrast, in cells pretreated with 1 mmol/L OTZ, the GSH/GSSG ratio markedly increased and GLO-I activity remained almost as high as in control cells not exposed to H-PDF ( Figure 5 ).
DISCUSSION
Our data confirm earlier reports that exposure to PDF reduces glutathione levels in HPMC (5) and show that this effect is associated with decreased GLO-I activity and reduced HPMC viability. These alterations appear to be related to the presence of GDP in PDF, since they are absent from HPMC treated with F-PDF containing no GDP. Therefore, one may hypothesize that, during clinical CAPD, the glyoxalase-glutathione pathway in HPMC may be not able to cope with the excessive load of GDP imposed by conventional PDF.
The observation that a decrease in intracellular glutathione correlates with reduced GLO-I activity may suggest a cause-effect relationship, with GSH limiting GLO-I activity. It appears, however, that the loss of cell viability and the degree of GSH depletion in response to 4.25%-glucose H-PDF were more profound than a decrease in GLO-I activity, possibly indicating that the level of cellular GSH affects HPMC viability more strongly than GLO-I activity. This may be due to the fact that GSH not only acts as a cofactor for GLO-I, but exerts many other biological effects important for cell defense (18) . It has been demonstrated that glyoxal and methylglyoxal can be effectively scavenged from PDF by the addition of GLO-I and GSH (7) . Although the levels of 3-deoxyglucosone also decreased to some extent, the exact role of GLO-I and GSH in mediating this effect is unclear because 3-deoxyglucosone is not a substrate of GLO-I (19). We found that conventional H-PDF display an improved biocompatibility profile toward mesothelial cells when pretreated with GLO-I and GSH. Interestingly, however, a similar effect could be achieved by GSH itself. Inagi et al. showed that GSH alone also eliminated glyoxal, methylglyoxal, and 3-deoxyglucosone, although slower than in the presence of GLO-I (7). Moreover, the experiments from Walker's group revealed that amino thiol compounds, including GSH, markedly reduced formaldehyde concentrations in PDF (20, 21) . This feature of GSH is important given the strong cytotoxic impact of formaldehyde on mesothelial cells (1,2).
Inagi's experiments clearly demonstrated that GDP removal by GLO-I-containing tissue extracts required the presence of GSH and strongly depended on its concentration. However, while GSH added to PDF may be effective as a GDP scavenging agent, its direct impact on HPMC GLO-I activity may be negligible. This is because most cells have a limited capacity for taking up intact GSH (18) . Therefore, supplementation with GSH precursors rather than GSH itself is a common way to increase intracellular GSH (22) . We found that the pre-exposure of HPMC to such a precursor (OTZ) maintained a high GSH/GSSG ratio and prevented the fall in GLO-I activity. In this respect, Brȩborowicz et al. have recently demonstrated that OTZ effectively reduces the adverse effects exerted by both individual GDP and GDP-containing PDF (23) . Results of the present study indicate that the protective effect of OTZ could be related, at least partially, to the preservation of high GLO-I activity.
It has been demonstrated that cells overexpressing GLO-I display improved function when exposed to methylglyoxal (7, 24) . However, it is unlikely that genetically mediated enhancement of GLO-I activity in HPMC will become a routine therapeutic strategy in the very near future. Therefore, the supplementation of PDF with glutathione (or glutathione precursors) may offer an interesting alternative. Our data show that this approach significantly reduces, at least, the acute toxicity of GDP toward the mesothelium (as reflected by improved viability and IL-6 production). However, the potential drawback of this method is that thiol compounds undergo autoxidation, giving rise to reactive oxygen species (25, 26) , which in the long term may jeopardize the integrity of the peritoneum.
Compartmentalization of PDF bags partially reduces GDP formation during autoclaving. However, toxic oxoaldehydes are also generated in vivo and, importantly, at an increased rate in uremia and diabetes. For that reason, the glyoxalase system in PDF would offer the advantage of also neutralizing oxoaldehydes that are diffusing into the peritoneal cavity from the systemic circulation. Figure 5 -Effect of L-2-oxothiazolidine-carboxylic acid (OTZ) on the glyoxalase I (GLO-I)/glutathione system in human peritoneal mesothelial cells (HPMC). HPMC were preincubated in the presence or absence of 1 mmol/L OTZ for 3 hours and then exposed to 4.25%-glucose heat-sterilized peritoneal dialysis fluids (H-PDF) mixed with an equal volume of culture medium. After 24 hours, the activity of GLO and the reduced glutathione/glutathione disulfide (GSH/GSSG) ratio were assessed in cell lysates. Control cells were maintained in standard culture medium and were not exposed to OTZ or H-PDF. Results of a representative experiment of two performed are shown.
